Searchable abstracts of presentations at key conferences in endocrinology

ea0050p020 | Adrenal and Steroids | SFEBES2017

How accurate are urinary metanephrines in screening for phaeochromocytoma?

Walsh Joseph , Spence Kirsty , McDonnell Margaret , Graham Una

The Endocrine Society recommends urinary or plasma metanephrines as first choice screening tests for phaeochromocytoma due to their high sensitivity. Test specificity is limited by the influence of many commonly prescribed medications resulting in false positive results and additional investigations. The aims of this retrospective study were to (1) Determine the diagnostic accuracy of urinary metanephrines using current cut-off values and (2) Evaluat...

ea0050p020 | Adrenal and Steroids | SFEBES2017

How accurate are urinary metanephrines in screening for phaeochromocytoma?

Walsh Joseph , Spence Kirsty , McDonnell Margaret , Graham Una

The Endocrine Society recommends urinary or plasma metanephrines as first choice screening tests for phaeochromocytoma due to their high sensitivity. Test specificity is limited by the influence of many commonly prescribed medications resulting in false positive results and additional investigations. The aims of this retrospective study were to (1) Determine the diagnostic accuracy of urinary metanephrines using current cut-off values and (2) Evaluat...

ea0069p28 | Poster Presentations | SFENCC2020

A case of macroTSH masquerading as subclinical hypothyroidism

D'Arcy Robert , McDonnell Margaret , Spence Kirsty , Refetoff Samuel , Hunter Steven

Case history: A 47 year old male presented to his GP with non-specific symptoms of fatigue and weight gain. Thyroid function tests revealed elevated TSH (28.4 mU/l) with normal Free T4 (14.3 pmol/l). Anti-TPO antibodies were undetectable. A presumptive diagnosis of subclinical hypothyroidism was made and he was commenced on Levothyroxine which was titrated over 9 months to 150 mcg/d given a persistently elevated TSH. The patient was unable to tolerate this dose due to the deve...

ea0028p319 | Steroids | SFEBES2012

The use of nocturnal salivary cortisol and urinary cortisol to creatinine ratio in the evaluation of cycling in patients with Cushing’s syndrome

Graham Una , Hunter Stephen , McDonnell Margaret , Mullan Karen , Atkinson Brew

Cyclical Cushing’s syndrome is typically detected by collecting sequential daily early morning urine (EMU) samples for cortisol to creatinine ratio over a 28 day period. More recently nocturnal salivary cortisol (NSC) measurement has been shown to be a sensitive means of screening for Cushing’s syndrome. The Endocrine Society have suggested that NSC may be used to assess patients for cyclical Cushing’s however there is limited evidence that it correlates with th...

ea0059p018 | Adrenal and steroids | SFEBES2018

The role of plasma metanephrines and plasma catecholamines in the biochemical testing for Pheochromocytoma

Spence Kirsty , Hunter Steven , Brown Campbell , Thompson Paul , Mullan Karen , McDonnell Margaret

First line screening for pheochromocytoma, as recommend by Endocrine Society guidelines, is to determine plasma free or urinary fractionated metanephrines. We routinely offer the latter. Although negative results rule out pheochromocytoma, it is not uncommon to see borderline results which require further investigation. In this situation we have historically relied on the measurement of plasma catecholamines in the clonidine suppression test (CST). Plasma metanephrines, howeve...

ea0065p214 | Metabolism and Obesity | SFEBES2019

Hypoglycaemia screen (hypopak) quality improvement audit

Spence Kirsty , Beckett Rachel , Hamilton Gillian , Alcheikh Mohammad , Heffernan Emmeline , Abid Noina , O'Sullivan Siobhan , Connolly Grainne , McDonnell Margaret

In Northern Ireland hypopaks (contains samples for glucose, lactate, hydroxybutyrate, insulin, growth hormone (GH), cortisol, amino acids, organic acids and acylcarnitines) are used to investigate hypoglycaemia in children. We aimed to assess the appropriateness of hypopak requests, to determine their usefulness in diagnosing endocrine and metabolic conditions and to determine if GH is helpful. Data for hypopaks received between 01 April 17 and 31 March 18 was analysed. Hypopa...

ea0066p63 | Learning from Mistakes and Miscellaneous | BSPED2019

The use of ‘Hypopaks’ in the investigation of hypoglycaemia in children

Beckett Rachel , Spence Kirsty , Hamilton Gillian , Alcheikh Mohammad , O'Sullivan Siobhan , Connolly Grainne , McDonnell Margaret , Abid Noina , Heffernan Emmeline

Introduction: When hypoglycaemia (blood glucose <2.6 mmol/l) is detected in a child a ‘Hypopak’ is sent, which tests for blood glucose, lactate, hydroxybutyrate, insulin, growth hormone, cortisol, amino acids, acylcarnitines, and urine organic acids. We aimed to determine whether samples were sent appropriately and completely, and whether a diagnosis ensued.Methods: All Hypopak samples received by the laboratory between 1/4/17 and 31/3/18 w...

ea0059p007 | Adrenal and steroids | SFEBES2018

Salivary cortisol determination using the Roche generation II assay

Spence Kirsty , McKeever Edward , Graham Una , Irwin Shirley , Neely Jeremy , McAlister Catherine , Courtney Hamish , Hunter Steven , Mullan Karen , McCance David , McDonnell Margaret

The Endocrine Society guidelines recommend initial testing for Cushing’s syndrome (CS) can be based on non-invasive late-night salivary cortisol measurement (NSC). In the BHSCT NSC (11pm), measured using the IBL ELISA kit has been found to be highly discriminative in identifying patients with CS. However it is a labour intensive test and the need for analysing samples in batches delays turnaround time, limiting its use in the routine work-up for CS. Roche provide an autom...